Howe Jolanda's Form 4 filing
Mirum Pharmaceuticals, Inc. (MIRM) · filed Aug 8, 2025
- Accession no.
- 0001415889-25-021351
- Filed
- Aug 8, 2025
- Trade date
- Aug 7, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $580.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Howe JolandaCIK 0001974200 | Officer (SVP, GLOBAL CONTROLLER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $6.27 | +$62,700 | 12,426 | Direct | |
| Aug 7, 2025 | Common Stock | SSaleDisposed | −10,000 | $58.00 | −$580,000 | 2,426 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2025 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 40,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.